Cost-Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand

ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s113559
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus

Frontiers in Pharmacology
Pharmacology
2017English

Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes

European Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2007English

Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
2016English

The Relationship Between Dipeptidyl Peptidase-4 Inhibitor Usage and Asymptomatic Amylase Lipase Increment in Type 2 Dıabetes Mellitus Patients

Turkish Journal of Pharmaceutical Sciences
Molecular MedicinePharmaceutical Science
2018English

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid

2019English

Effectiveness in Clinical Practice Versus Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Clinical Trials for Type 2 Diabetes: Protocol for Systematic Review

BMJ Open
Medicine
2019English

Efficacy of High-Dose Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Glycemic Parameters in Patients With Type 2 Diabetes Estimated With Continuous Glucose Monitoring: A Pilot Study

Integrative Obesity and Diabetes
2017English

Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients With Type 2 Diabetes

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy